MEDINEX LIMITED (OTX) Fair Value & Analysis
Healthcare · SG · Market cap 30.9M SGD
Fair value as of: Aug 13, 2026
From 22 valuation models · updated 5 days ago
Share price +2.3% over the past month.
A strong business, screening 42% undervalued on our models.
What matters now
- The rarer combination: high quality (75/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (0.2400 SGD). The market is more pessimistic than our downside scenario.
- A fairly wide model range (0.2400 SGD to 0.4500 SGD) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 0.1374 SGD – 0.2500 SGD · fair‑value band 0.2400 SGD – 0.4500 SGD · the 0.2250 SGD price screens below the 0.3200 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
MEDINEX LIMITED (OTX) currently trades at 0.2250 SGD, while our model-based Fair Value estimate is 0.3200 SGD, implying the stock looks roughly 42.2% undervalued today. The Quality Score stands at 75/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, MEDINEX LIMITED generated revenue of 12.4M SGD at a net margin of 17.9%. Revenue declined 3.0% year over year. It earns a return on equity of 13.4%. The stock trades on a trailing P/E of 11.3. Fundamentals as of Aug 13, 2026
Our scenario range runs from 0.2400 SGD (bear case) to 0.4500 SGD (bull case); at 0.2250 SGD, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 10% below its 52-week high and 18% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -31% fair-value upside, at 42%, OTX screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: Multiples (0.3000 SGD) versus Asset-Based (0.0800 SGD). Highest evidence: Growth DCF (80).
Notify me when OTX reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 74 · Market factors (momentum, volatility) 54
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Medinex Limited, an investment holding company, provides professional support services to medical clinics in Singapore. It operates through four segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services.
Full company description
Medinex Limited, an investment holding company, provides professional support services to medical clinics in Singapore. It operates through four segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. The company engages in the setting up of clinics, facilitating applications for relevant clinic licenses, value added services to healthcare sectors, turnkey solutions, as well as strategic advice to general practitioners and specialists on establishing clinic facilities. It also provides accounting and tax agent, human resource management, and corporate secretarial services, as well as business support services, such as accounting, tax agent, human resource management, and corporate secretarial services to various sectors, such as food and beverage, retail, education, and beauty. In addition, the company procures medical and pharmaceutical products to clinics. Further, the company offers diagnostic and x-rays, pre-employment check-ups, vaccination, customized healthcare plans, and health screening services in clinics. Additionally, it provides advisory services, and business and management consultancy services, call support services, and data protection officer services to its customers; and training services. Medinex Limited was incorporated in 2009 and is headquartered in Singapore.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
MEDINEX LIMITED reported revenue of 12.4M SGD in FY2026 versus 12.0M SGD in FY2022, a compound +0.9%/yr. Reported net income was 2.2M SGD in FY2026, compounding −5.7%/yr from FY2022.
Watch OTX: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 268 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.09 | R$47.31 | +43% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
| Fortis Healthcare Limited FORTIS | ₹906.15 | ₹300.29 | -67% |
Compare MEDINEX LIMITED with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is MEDINEX LIMITED (OTX) overvalued or undervalued?
What is the fair value of OTX?
What is the quality score of OTX?
What is the revenue of MEDINEX LIMITED (OTX)?
What is the net profit margin of OTX?
Does MEDINEX LIMITED pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track MEDINEX LIMITED and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.